Grand Prize Dream Vacation Awarded to Curly’s® Cruisin’ Summer Sweepstakes Winner
Aug 02, 2017 20:00 pm UTC| Business
PEWAUKEE, Wis., Aug. 02, 2017 -- Curly’s®, the leading name in ready-to-eat BBQ across the U.S., has announced the grand prize winner of the brand’s Cruisin’ Summer Sweepstakes. On Friday, July 21, 30-year-old Jasmine...
CPS Technologies Corporation Announces Second Quarter 2017 Results
Aug 02, 2017 20:00 pm UTC| Business
NORTON, Mass., Aug. 02, 2017 -- CPS Technologies Corporation (NASDAQ:CPSH) today announced revenues of $3.7 million and a net loss of $333 thousand for the quarter ended July 1, 2017. This compares with revenues of...
Aug 02, 2017 20:00 pm UTC| Business
LYNNWOOD, Wash., Aug. 02, 2017 -- Zumiez Inc. (NASDAQ:ZUMZ) a leading specialty retailer of apparel, footwear, equipment and accessories for young men and women today announced that total net sales for the four-week...
Qorvo® Announces Fiscal 2018 First Quarter Results
Aug 02, 2017 20:00 pm UTC| Business
GREENSBORO, N.C., Aug. 02, 2017 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced financial results for the Company’s fiscal 2018 first quarter, ended July 1,...
MYR Group Inc. Announces Second-Quarter and First-Half 2017 Results
Aug 02, 2017 20:00 pm UTC| Business
ROLLING MEADOWS, Ill., Aug. 02, 2017 -- MYR Group Inc. (“MYR”) (NASDAQ:MYRG), a holding company of leading specialty contractors serving the electrical infrastructure market in the United States and Canada, today...
OraSure Announces 2017 Second Quarter Financial Results
Aug 02, 2017 20:00 pm UTC| Business
BETHLEHEM, Pa., Aug. 02, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and...
Cytokinetics, Inc. Reports Second Quarter 2017 Financial Results
Aug 02, 2017 20:00 pm UTC| Business
Results Expected from VITALITY-ALS, Our Phase 3 Clinical Trial of Tirasemtiv, in Q4 2017 CK-2127107 Advancing in Four Clinical Trials Under Our Collaboration with Astellas Omecamtiv Mecarbil Phase 3 Clinical Trial...